Ellis Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $901K | Buy |
1,156
+2
| +0.2% | +$1.56K | 0.18% | 102 |
|
|
2025
Q1 | $953K | Sell |
1,154
-55
| -5% | -$45.4K | 0.2% | 98 |
|
|
2024
Q4 | $933K | Buy |
1,209
+82
| +7% | +$63.3K | 0.18% | 101 |
|
|
2024
Q3 | $998K | Sell |
1,127
-116
| -9% | -$103K | 0.19% | 98 |
|
|
2024
Q2 | $1.12M | Buy |
1,243
+102
| +9% | +$92.3K | 0.24% | 83 |
|
|
2024
Q1 | $888K | Sell |
1,141
-69
| -6% | -$53.7K | 0.19% | 96 |
|
|
2023
Q4 | $706K | Sell |
1,210
-160
| -12% | -$93.3K | 0.16% | 110 |
|
|
2023
Q3 | $736K | Hold |
1,370
| – | – | 0.19% | 97 |
|
|
2023
Q2 | $643K | Buy |
1,370
+359
| +36% | +$168K | 0.16% | 113 |
|
|
2023
Q1 | $347K | Buy |
1,011
+154
| +18% | +$52.9K | 0.09% | 157 |
|
|
2022
Q4 | $314K | Sell |
857
-15
| -2% | -$5.49K | 0.09% | 162 |
|
|
2022
Q3 | $282K | Buy |
872
+3
| +0.3% | +$970 | 0.08% | 159 |
|
|
2022
Q2 | $281K | Buy |
869
+3
| +0.3% | +$970 | 0.08% | 164 |
|
|
2022
Q1 | $248K | Buy |
866
+3
| +0.3% | +$859 | 0.06% | 188 |
|
|
2021
Q4 | $238K | Buy |
863
+111
| +15% | +$30.6K | 0.05% | 197 |
|
|
2021
Q3 | $173K | Buy |
752
+73
| +11% | +$16.8K | 0.04% | 231 |
|
|
2021
Q2 | $156K | Buy |
679
+101
| +17% | +$23.2K | 0.04% | 242 |
|
|
2021
Q1 | $108K | Sell |
578
-7
| -1% | -$1.31K | 0.03% | 278 |
|
|
2020
Q4 | $99K | Sell |
585
-164
| -22% | -$27.8K | 0.03% | 284 |
|
|
2020
Q3 | $111K | Buy |
749
+2
| +0.3% | +$296 | 0.04% | 250 |
|
|
2020
Q2 | $122K | Buy |
747
+3
| +0.4% | +$490 | 0.05% | 227 |
|
|
2020
Q1 | $101K | Buy |
744
+135
| +22% | +$18.3K | 0.05% | 192 |
|
|
2019
Q4 | $80K | Buy |
609
+2
| +0.3% | +$263 | 0.03% | 270 |
|
|
2019
Q3 | $67K | Buy |
607
+526
| +649% | +$58.1K | 0.02% | 295 |
|
|
2019
Q2 | $9K | Buy |
+81
| New | +$9K | ﹤0.01% | 534 |
|